Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jackie Norrie

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Biorxiv : the Preprint Server for Biology|May 25, 2026
Active repression of muscle fate preserves neural lineage identity during cerebellum developmentNurunnabi Mirja Shaikh, Venkata Thulabandu, Akira Inoue, et al.
Biorxiv : the Preprint Server for Biology|October 31, 2023
Identification of Evolutionarily Conserved VSX2 Enhancers in Retinal DevelopmentVictoria Honnell, Shannon Sweeney, Jackie Norrie, et al.
Development (Cambridge, England)|July 12, 2024
Evolutionary conservation of VSX2 super-enhancer modules in retinal developmentVictoria Honnell, Shannon Sweeney, Jackie Norrie, et al.
Nature Communications|February 16, 2020
MYCN amplification and ATRX mutations are incompatible in neuroblastomaMaged Zeineldin, Sara Federico, Xiang Chen, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Biorxiv : the Preprint Server for Biology|May 25, 2026
Active repression of muscle fate preserves neural lineage identity during cerebellum developmentNurunnabi Mirja Shaikh, Venkata Thulabandu, Akira Inoue, et al.
Biorxiv : the Preprint Server for Biology|October 31, 2023
Identification of Evolutionarily Conserved VSX2 Enhancers in Retinal DevelopmentVictoria Honnell, Shannon Sweeney, Jackie Norrie, et al.
Development (Cambridge, England)|July 12, 2024
Evolutionary conservation of VSX2 super-enhancer modules in retinal developmentVictoria Honnell, Shannon Sweeney, Jackie Norrie, et al.
Nature Communications|February 16, 2020
MYCN amplification and ATRX mutations are incompatible in neuroblastomaMaged Zeineldin, Sara Federico, Xiang Chen, et al.
Pageof 1